Tampere Epilepsy Research Group

Dedicated to improving the quality of life for patients with Epilepsy

[Tampere Epilepsy Research Group @TampEpilep]

https://t.co/s4ZTP3SMsI

[Tampere Epilepsy Research Group @TampEpilep]

https://t.co/yTTMdB0sPg

[Tampere Epilepsy Research Group @TampEpilep]

VNS does more than reduce seizures in drug-resistant #epilepsy: A new study led by professor Jukka Peltola reveals patients with depressive symptoms may have even better seizure control with #VNS! 🧠⚡
https://t.co/3sB8cY9LA5
@Epilepsialiitto @SuomenNeuro @NeurocenterFI

[Tampere Epilepsy Research Group @TampEpilep]

Professor Jukka Peltola delivering his talk @KuopioEpilepsy symposium on “home monitoring possibilities of epileptic seizures” @rkalviainen @Tre_Brain_Mind @NeurocenterFI #KES2024 @neuroeventlabs

[Tampere Epilepsy Research Group @TampEpilep]

Participating virtually @KuopioEpilepsy @rkalviainen

[Tampere Epilepsy Research Group @TampEpilep]

@KuopioEpilepsy When do virtual participants receive the link to join the event ?

[Tampere Epilepsy Research Group @TampEpilep]

https://t.co/mTeqqqOEud

[Tampere Epilepsy Research Group @TampEpilep]

💡Navigating the Complex World of Epilepsy Comorbidities: Expert Insights! https://t.co/NG147oltwV offers practical, evidence-based advice to empower neurologists in the care of patients with epilepsy @jukka_nekujupe @NeurocenterFI @Tre_Brain_Mind @Epilepsialiitto @Tays_sairaala

[Tampere Epilepsy Research Group @TampEpilep]

Peltola et al. present results from MORE registry supporting the effectiveness and safety of ANT-DBS therapy in a real-world setting, including drug-resistant focal epilepsy patients from 25 centers and 13 countries @jukka_nekujupe @Medtronic
https://t.co/Nniul7WRDO

[Tampere Epilepsy Research Group @TampEpilep]

Our results not only provides additional pathophysiologic significance of IL-6 but also offers a new possibility of therapeutic intervention, in the treatment of GADA-induced autoimmune epilepsy, read more https://t.co/0kZDwYW1Ig
@jukka_nekujupe @NeurocenterFI
@Tre_Brain_Mind

[Tampere Brain & Mind @Tre_Brain_Mind]

Lectio precursia: Erittäin aktiivisen aaltomaisen MS-taudin lääkehoitojen turvallisuus.
Väittelijä: Ilkka Rauma
Vastaväittäjä: dosentti Eero Rissanen, @UniEastFinland
Kustos: Professori Jukka Peltola, @TampereUni

#tamperebrainandmind
#codedtoconnect
@NeurocenterFI

[Tampere Epilepsy Research Group @TampEpilep]

In an interview at the 14th European Epilepsy Congress 2022 in Geneva, Prof. Peltola shares insights on the use of ANT-DBS in patients with drug-resistant epilepsy @jukka_nekujupe @NeurocenterFI @Tre_Brain_Mind @Epilepsialiitto https://t.co/WkPcylEUu3

[Reetta Kälviäinen @rkalviainen]

.@jukka_nekujupe @TampEpilep @Tre_Brain_Mind presents new outcome results of deep brain stimulation treatment in epilepsy on last day of #eec2022 @IlaeWeb

[Tampere Epilepsy Research Group @TampEpilep]

Home videos can improve #epilepsy care and management. Our study confirms the clinical utility of seizure monitoring system #Nelli® at patients' home. Read more at https://t.co/FAEqydDab1 @NeurocenterFI @Tre_Brain_Mind @Tays_sairaala @TampereUni @TampereUniMET @neuroeventlabs

[Tampere Epilepsy Research Group @TampEpilep]

Interesting case report on the positive effects of VNS on controlling the “cytokine storm” associated with COVID-19. #COVID19 https://t.co/iM5zbU6Qxr

[Tampere Brain & Mind @Tre_Brain_Mind]

Prof. Jukka Peltola: Tärkein tavoitteemme on saada kaikki tutkijat ja yritykset, jotka ovat tekemisissä aivotutkimuksen kanssa - laajasti ajateltuna - yhteistyöhön ja etsimään synergiaetuja Tampereella ja koko Suomessa #codedtoconnect @TampereUni @Tays_sairaala @jukka_nekujupe

[Tampere Epilepsy Research Group @TampEpilep]

Combined AI and human expertise, without EEG, for reviewing nocturnal video recordings significantly decreases the workload and provides accurate classification of major motor seizures in Epilepsy @neuroeventlabs @NeurocenterFI @Epilepsialiitto https://t.co/rcL5QaKqTf

[Neurology Journal @GreenJournal]

What #neuromodulation devices will neurologists in 2035 have access to? Read the latest article in the #Neurology Future Forecasting Series to learn more: https://t.co/k1fvNkH7UP

[Tampere Epilepsy Research Group @TampEpilep]

A single-centre follow-up study of 263 epilepsy patients (2009-2018) @Tays_sairaala reports exciting results on treatment outcomes in women with idiopathic generalized epilepsy: highlighting valproate and its alternatives. https://t.co/tSpjDZmkz2 @jukka_nekujupe @NeurocenterFI

[Tampere Epilepsy Research Group @TampEpilep]

COVID‐19 vaccine take‐up rate and safety in adults with epilepsy: Data from a multicenter study in China https://t.co/MWmVKGki67